Showing posts with label Tofacitinib. Show all posts
Showing posts with label Tofacitinib. Show all posts
Friday, July 27, 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

›
In continuation of my update on  Tofacitinib The U.S. Food and Drug Administration  expanded the approval of Xeljanz ( tofacitin...
Monday, February 12, 2018

Pfizer Announces FDA Approval of Xeljanz (tofacitinib) and Xeljanz XR for the Treatment of Active Psoriatic Arthritis

›
In continuation of my update on tofacitinib   Pfizer Inc.  announced that the United States Food and Drug Administration (FDA) has ap...
Friday, June 1, 2012

FDA AAC recommends approval of Pfizer’s tofacitinib for RA

›
In continuation of my update on  Tofacitinib ... FDA AAC recommends approval of Pfizer’s tofacitinib for RA : Pfizer Inc. the Arthriti...
Wednesday, May 23, 2012

Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill

›
In continuation of my update on Tofacitinib Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill : Pfizer is waiting...
Monday, May 9, 2011

Pfizer RA Drug Meets Study Goals

›
We knew that,   Tofacitinib  (see structure, formerly  tasocitinib  is a drug being investigated by Pfizer for the treatment of rheuma...
Saturday, April 30, 2011

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

›
In continuation of my update on drugs discovery on   rheumatoid arthritis ,  Top-line results from Pfizer's tofacitinib Phase...